Cite
Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy.
MLA
Geraix, Juliana, et al. “Bezafibrate for the Treatment of Hypertriglyceridemia in HIV1-Infected Patients on Highly Active Antiretroviral Therapy.” The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, vol. 10, no. 3, June 2006, pp. 159–64. EBSCOhost, https://doi.org/10.1590/s1413-86702006000300001.
APA
Geraix, J., de Souza, M. E., Delatim, F. C., & Pereira, P. C. M. (2006). Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, 10(3), 159–164. https://doi.org/10.1590/s1413-86702006000300001
Chicago
Geraix, Juliana, Micheli Evangelista de Souza, Francieli Cristina Delatim, and Paulo Câmara Marques Pereira. 2006. “Bezafibrate for the Treatment of Hypertriglyceridemia in HIV1-Infected Patients on Highly Active Antiretroviral Therapy.” The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases 10 (3): 159–64. doi:10.1590/s1413-86702006000300001.